CASI Pharmaceuticals(CH:ENM)
CH:ENM
CASI Pharmaceuticals earnings date
CASI Pharmaceuticals (ENM) Q2 2022 Earnings Report
0 Followers
CH:ENM Q2 2022 EPS Results
- Actual EPS
- -CHF 0.47
- Consensus EPS
- -CHF 0.53
- Beat/Miss
- Beat by +CHF 0.06
- One Year Ago EPS
- -CHF 0.42
CH:ENM Q2 2022 Revenue Results
- Actual Revenue
- CHF 7.19M
- Expected Revenue
- CHF 6.62M
- Beat/Miss
- Beat by +CHF 570.03K
- YoY Revenue Growth
- +20.00%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/12/2022
- Time
- Before Open
- Conference Call
- Friday, August 12, 2022
CH:ENM Upcoming Earnings
CASI Pharmaceuticals's next earnings date is estimated for May 20, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ENM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 20, 2027 | 2027 (Q1) | ―- | ― | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | ―- | -0.57 | ― | |
| Aug 14, 2026 | 2026 (Q2) | ―-0.82 | -0.72 | -13.37% (-0.10) | |
| May 14, 2026 | 2026 (Q1) | ―- | -0.58 | ― | |
| Apr 29, 2026 | 2025 (Q4) | ―- | -0.58 | ― | |
| Nov 14, 2025 | 2025 (Q3) | -0.34-0.57 | -0.46 | -23.64% (-0.11) | |
| Aug 29, 2025 | 2025 (Q2) | -0.40-0.72 | -0.44 | -65.38% (-0.29) | |
| May 16, 2025 | 2025 (Q1) | ―-0.58 | -0.6 | 2.82% (+0.02) | |
| Mar 31, 2025 | 2024 (Q4) | -0.51-0.58 | -0.6 | 2.82% (+0.02) | |
| Nov 15, 2024 | 2024 (Q3) | -0.52-0.46 | -0.29 | -57.14% (-0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

